LEADER 01876nas 2200541-a 450 001 996335758703316 005 20240413021643.0 035 $a(CKB)963018283166 035 $a(CONSER)---94641462- 035 $a(EXLCZ)99963018283166 100 $a19940221b19942005 --- a 101 0 $aeng 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aBehavioral health management 210 $aCleveland, OH $cMEDQUEST Communications$d©1994-©2005 215 $a1 online resource 300 $aTitle from cover. 311 08$aPrint version: Behavioral health management. 1075-6701 (DLC) 94641462 (OCoLC)29851428 531 0 $aBehav. health man. 606 $aManaged mental health care$zUnited States$vPeriodicals 606 $aAlcoholism$xrehabilitation 606 $aAlcoholism$xtherapy 606 $aManaged Care Programs 606 $aMental Disorders$xtherapy 606 $aSubstance-Related Disorders$xrehabilitation 606 $aSubstance-Related Disorders$xtherapy 606 $aManaged mental health care$2fast$3(OCoLC)fst01007134 607 $aUnited States 607 $aUnited States$2fast$1https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq 608 $aPeriodical. 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 615 0$aManaged mental health care 615 2$aAlcoholism$xrehabilitation. 615 2$aAlcoholism$xtherapy. 615 2$aManaged Care Programs. 615 2$aMental Disorders$xtherapy. 615 2$aSubstance-Related Disorders$xrehabilitation. 615 2$aSubstance-Related Disorders$xtherapy. 615 7$aManaged mental health care. 676 $a362.29/05 906 $aJOURNAL 912 $a996335758703316 920 $aexl_impl conversion 996 $aBehavioral health management$92391798 997 $aUNISA LEADER 03090nam 2200637Ia 450 001 9910142970003321 005 20200520144314.0 010 $a1-282-05806-1 010 $a9786612058066 010 $a92-4-068357-7 035 $a(CKB)1000000000754426 035 $a(EBL)434245 035 $a(OCoLC)550640999 035 $a(SSID)ssj0000288923 035 $a(PQKBManifestationID)11218616 035 $a(PQKBTitleCode)TC0000288923 035 $a(PQKBWorkID)10384595 035 $a(PQKB)11249376 035 $a(MiAaPQ)EBC434245 035 $a(Au-PeEL)EBL434245 035 $a(CaPaEBR)ebr10294883 035 $a(CaONFJC)MIL205806 035 $a(EXLCZ)991000000000754426 100 $a20081027d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAnti-tuberculosis drug resistance in the world $efourth global report : the World Health Organization/International Union Against Tuberculosis and Lung Disease (WHO/UNION) Global Project on Anti-Tuberculosis Drug Resistance Surveillance, 2002-2007 /$f[written by Abigail Wright, Matteo Zignol] 205 $a1st ed. 210 $aGeneva, Switzerland $cWorld Health Organization$dc2008 215 $a1 online resource (152 p.) 300 $a"WHO/HTM/TB/2008.394." 311 $a92-4-156361-3 320 $aIncludes bibliographical references (p. 97-100). 327 $aCover; Title; Copyright; Contents; Contributors; GLOBAL NETWORK OF SUPRANATIONAL REFERENCE LABORATORIES; EXECUTIVE SUMMARY; CONCLUSIONS; Chapter 1. INTRODUCTION; Chapter 2. METHODS; Chapter 3. RESULTS; Chapter 4. DISCUSSION; References; Annex 1; Annex 2; Annex 3; Annex 4; Annex 5 330 $aMultidrug-resistant tuberculosis (MDR-TB) has been recorded at the highest rates ever, according to this new report that presents findings from the largest survey to date on the scale of drug resistance in tuberculosis.This fourth global report is based on information collected between 2002 and 2006 on 90,000 TB patients in 81countries. It also found that extensively drug-resistant tuberculosis (XDR-TB), a virtually untreatable form of therespiratory disease, has been recorded in 45 countries. The primary aim of this report is to share survey and surveillance data on drug resistance in TB. The 517 3 $aWHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance 606 $aTuberculosis$xPrevention$vStatistics 606 $aMultidrug-resistant tuberculosis$vStatistics 606 $aDrug resistance$vStatistics 615 0$aTuberculosis$xPrevention 615 0$aMultidrug-resistant tuberculosis 615 0$aDrug resistance 676 $a614.5/42 700 $aWright$b Abigail$0946691 701 $aZignol$b Matteo$0946692 712 02$aWHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910142970003321 996 $aAnti-tuberculosis drug resistance in the world$92138898 997 $aUNINA